BioCentury
ARTICLE | Clinical News

Bladder Cancer Assay diagnostic data

January 31, 2011 8:00 AM UTC

A trial in urine samples from patients with bladder cancer and healthy controls showed that Predictive's CertNDx Bladder Cancer Assay using MMP2, FGFR3, TWIST1 and NID2 biomarkers had 94% specificity and a 99.5% negative predictive value (NPV) for detecting bladder cancer. Data were presented at the GTCbio Oncology Biomarkers meeting in San Diego. ...